Brazil sets out strategy for control dengue in 2003
This article was originally published in Clinica
The Brazilian health ministry has set out ambitious goals for its R$1bn (US$331m) dengue control programme (PNCD) in 2003. At a meeting in Brasilia last week, the newly-created PNCD committee announced a target of halving this year's incidence of the disease, and of reducing to 1% the death rate associated with the haemorrhagic form of the condition. Early diagnosis is the key to controlling the disease in its milder form, following infection from one serotype, prior to its progression to the haemorrhagic form, through exposure to a different serotype (see Clinica No 1001, p 14).
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.